Last reviewed · How we verify
Topical Foam
At a glance
| Generic name | Topical Foam |
|---|---|
| Also known as | Disinfectant |
| Sponsor | Minia University |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Topical or Oral Minoxidil for the Treatment of Endocrine Therapy-Induced Alopecia in Patients With Stage I-IV Breast Cancer (EARLY_PHASE1)
- Topical Minocycline for CARP (EARLY_PHASE1)
- Clinical Trial to Evaluate CG2001 in Chinese Adult Male Participants With Androgenetic Alopecia (PHASE2)
- Topical Vaginal Estrogen for Postpartum Obstetric Anal Sphincter Injury Recovery (PHASE4)
- The Safety and Efficacy of Roflumilast Foam in HS (PHASE2)
- Pilot Study of MammoGRIP for Breast Positioning, Image Quality, and Patient Comfort in Mammography (NA)
- A Study for Evaluating Safety & Efficacy of Topical Roflumilast 0.3% Foam in Hidradenitis Suppurativa (PHASE2)
- Fibroblast Growth Factor Regeneration of Tympanic Membrane Perforations (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Topical Foam CI brief — competitive landscape report
- Topical Foam updates RSS · CI watch RSS
- Minia University portfolio CI